| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41598-020-70892-4 |
| P698 | PubMed publication ID | 32807826 |
| P50 | author | Ana Luiza Maia | Q56951835 |
| Mariana Recamonde-Mendoza | Q57655186 | ||
| P2093 | author name string | Iuri Martin Goemann | |
| Marcia Silveira Graudenz | |||
| Simone Magagnin Wajner | |||
| Vicente Rodrigues Marczyk | |||
| P2860 | cites work | Type 1 iodothyronine deiodinase in human physiology and disease: Deiodinases: the balance of thyroid hormone | Q22305979 |
| Type 3 lodothyronine deiodinase: cloning, in vitro expression, and functional analysis of the placental selenoenzyme | Q24316249 | ||
| Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 | ||
| A gene-expression signature as a predictor of survival in breast cancer | Q27860945 | ||
| Molecular portraits of human breast tumours | Q28032461 | ||
| Type 3 deiodinase: role in cancer growth, stemness, and metabolism | Q28080881 | ||
| Physiological and molecular basis of thyroid hormone action | Q28203934 | ||
| The gene locus encoding iodothyronine deiodinase type 3 (Dio3) is imprinted in the fetus and expresses antisense transcripts | Q28210642 | ||
| Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype | Q28271274 | ||
| Increased type 3 deiodinase expression in papillary thyroid carcinoma | Q28271602 | ||
| Localization of the type 3 iodothyronine deiodinase (DIO3) gene to human chromosome 14q32 and mouse chromosome 12F1 | Q28286519 | ||
| A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer | Q28297827 | ||
| Genomic imprinting: parental influence on the genome | Q29616227 | ||
| Supervised risk predictor of breast cancer based on intrinsic subtypes | Q29617404 | ||
| limma powers differential expression analyses for RNA-sequencing and microarray studies | Q29617988 | ||
| US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status | Q30665329 | ||
| TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data | Q31034005 | ||
| Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells | Q31039079 | ||
| A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms | Q33502760 | ||
| Comparison of the seleno-transcriptome expression between human non-cancerous mammary epithelial cells and two human breast cancer cell lines | Q33599250 | ||
| Epigenetic silencing of genes and microRNAs within the imprinted Dlk1-Dio3 region at human chromosome 14.32 in giant cell tumor of bone | Q33913401 | ||
| 3, 3'5 Triiodo L thyronine induces apoptosis in human breast cancer MCF-7 cells, repressing SMP30 expression through negative thyroid response elements | Q33936933 | ||
| Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women | Q34048100 | ||
| IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells | Q34182213 | ||
| Determinants of iodothyronine deiodinase activities in rodent uterus | Q34228495 | ||
| Thyroid hormone inactivation in gastrointestinal stromal tumors | Q34294545 | ||
| Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. | Q34536780 | ||
| 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer | Q34538363 | ||
| Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. | Q34667516 | ||
| Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials | Q35740423 | ||
| Phenolic and tyrosyl ring deiodination of iodothyronines in rat brain homogenates | Q37028197 | ||
| Deregulation of small non-coding RNAs at the DLK1-DIO3 imprinted locus predicts lung cancer patient outcome. | Q37697098 | ||
| Breast cancer molecular subtypes--modern therapeutic concepts for targeted therapy of a heterogeneous entity | Q38047432 | ||
| Type 3 deiodinase and solid tumors: an intriguing pair. | Q38132760 | ||
| Changing Treatment Paradigms in Metastatic Breast Cancer: Lessons Learned | Q38548394 | ||
| Thyroid Hormone Controls Breast Cancer Cell Movement via Integrin αV/β3/SRC/FAK/PI3-Kinases. | Q38723074 | ||
| Influence of estradiol and triiodothyronine on breast cancer cell lines proliferation and expression of estrogen and thyroid hormone receptors | Q39770073 | ||
| Effects of thyroid hormones on human breast cancer cell proliferation | Q40004461 | ||
| Regulation of type III iodothyronine deiodinase expression in human cell lines. | Q40239097 | ||
| Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor | Q40570878 | ||
| Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to risk of different breast cancer subgroups: a Malmö Diet and Cancer Study | Q41701486 | ||
| The Concerted Action of Type 2 and Type 3 Deiodinases Regulates the Cell Cycle and Survival of Basal Cell Carcinoma Cells | Q42504260 | ||
| Genomic imprinting of DIO3, a candidate gene for the syndrome associated with human uniparental disomy of chromosome 14. | Q42746311 | ||
| Role for inner ring deiodination preventing transcutaneous passage of thyroxine | Q44467101 | ||
| Triiodothyronine levels in relation to mortality from breast cancer and all causes: a population-based prospective cohort study | Q44584384 | ||
| Effect of 3,5,3'-triiodothyronine-induced hyperthyroidism on iodothyronine metabolism in the rat: evidence for tissue differences in metabolic responses | Q48686545 | ||
| Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer | Q49447563 | ||
| Role of thyroid hormones in the neoplastic process: an overview. | Q50012200 | ||
| Regulation and function of deiodinases during decidualization in female mice. | Q51141810 | ||
| Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications. | Q53658742 | ||
| Current concepts and challenges to unravel the role of iodothyronine deiodinases in human neoplasias | Q58547723 | ||
| Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Q60142201 | ||
| Thyroid Hormones and Cancer: A Comprehensive Review of Preclinical and Clinical Studies | Q64260591 | ||
| β-Catenin regulates deiodinase levels and thyroid hormone signaling in colon cancer cells | Q84539637 | ||
| Thyroid hormone receptor beta-1 expression in early breast cancer: a validation study | Q89145859 | ||
| Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort | Q89183986 | ||
| Downregulation of Type 3 Deiodinase in the Hypothalamus During Inflammation | Q91860551 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 13914 | |
| P577 | publication date | 2020-08-17 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Decreased expression of the thyroid hormone-inactivating enzyme type 3 deiodinase is associated with lower survival rates in breast cancer | |
| P478 | volume | 10 |
Search more.